Potential of adenosine receptor agonists for the prevention and treatment of coronary artery disease and acute myocardial infarction

Author： Clark K.L.   Merkel L.  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.5, Iss.1, 2000-02, pp. : 89-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Prevention of Reperfusion Injury in Acute Myocardial Infarction: A Potential Role for Adenosine as a Therapeutic Agent

By Quintana M.  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 3, 2004-01 ,pp. : 159-167

Adis International

Access to resources Recommend Favorite

Inflammation in Coronary Artery Disease and Acute Myocardial Infarction - is the Stage Set for Novel Therapies?

By  

Current Pharmaceutical Design, Vol. 18, Iss. 28, 2012-09 ,pp. : 4358-4369

Bentham Science Publishers

Access to resources Recommend Favorite

The need for pharmaceutical care in the prevention of coronary heart disease: an exploratory study in acute myocardial infarction patients

By Chinwong Surarong   Reid Fiona   McGlynn Steve   Hudson Steve   Flapan Andy  

Pharmacy World and Science, Vol. 26, Iss. 2, 2004-04 ,pp. : 96-101

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic potential of H3-receptor agonists in myocardial infarction

By Mackins C.J.   Levi R.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2537-2542

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of GP IIb/IIIa receptor antagonists in acute myocardial infarction

By Ferguson James J   Vaisman Dan  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 11, 2001-11 ,pp. : 1965-1976

Informa Healthcare

Access to resources Recommend Favorite